Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses

There is increasing evidence that viral infections are the source/origin of various types of encephalitis, encephalomyelitis, and other neurological and cognitive disorders. While the involvement of certain viruses, such as the Nipah virus and measles virus, is known, the mechanisms of neural invasion and the factors that trigger intense immune reactions are not fully understood. Based on recent publications, this review discusses the role of the immune response, interactions between viruses and glial cells, and cytokine mediators in the development of inflammatory diseases in the central nervous system. It also highlights the significant gaps in knowledge regarding these mechanisms.

[1]  A. Lophatananon,et al.  Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank , 2022, PloS one.

[2]  J. Echevarria-Lima,et al.  Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM/TSP Development , 2022, Viruses.

[3]  C. Ng,et al.  Neuronal infection is a major pathogenetic mechanism and cause of fatalities in human acute Nipah virus encephalitis , 2022, Neuropathology and applied neurobiology.

[4]  R. Mahieux,et al.  Immunoprofiling of fresh HAM/TSP blood samples shows altered innate cell responsiveness , 2021, PLoS neglected tropical diseases.

[5]  Marco Antonio de Melo Tavares de Lima,et al.  Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression , 2021, Frontiers in Immunology.

[6]  N. Dorrello,et al.  Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain , 2021, mBio.

[7]  N. Messaddeq,et al.  Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection , 2020, Nature Communications.

[8]  M. Santos,et al.  Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life , 2020, PLoS neglected tropical diseases.

[9]  K. Tyler,et al.  The Role of Microglia during West Nile Virus Infection of the Central Nervous System , 2020, Vaccines.

[10]  S. Salinas,et al.  Neurocognitive impacts of arbovirus infections , 2020, Journal of Neuroinflammation.

[11]  H. Keyvani,et al.  The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis , 2020, Journal of Neuroimmunology.

[12]  R. Mahieux,et al.  HTLV-1 infection of myeloid cells: from transmission to immune alterations , 2019, Retrovirology.

[13]  B. Horvat,et al.  Measles Encephalitis: Towards New Therapeutics , 2019, Viruses.

[14]  J. Kuhn,et al.  Nipah virus persists in the brains of nonhuman primate survivors. , 2019, JCI insight.

[15]  R. Klein,et al.  T cells promote microglia-mediated synaptic elimination and cognitive dysfunction during recovery from neuropathogenic flaviviruses , 2019, Nature Neuroscience.

[16]  D. Gerlier,et al.  Type I Interferon Receptor Signaling Drives Selective Permissiveness of Astrocytes and Microglia to Measles Virus during Brain Infection , 2019, Journal of Virology.

[17]  Zhuangzhuang Chen,et al.  The role of microglia in viral encephalitis: a review , 2019, Journal of neuroinflammation.

[18]  F. Cosset,et al.  Sensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation , 2019, PLoS pathogens.

[19]  W. Löscher,et al.  Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update , 2019, International journal of molecular sciences.

[20]  B. Eley,et al.  Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain , 2018, Journal of Virology.

[21]  R. Gallo,et al.  Time to eradicate HTLV-1: an open letter to WHO , 2018, The Lancet.

[22]  S. Perlman,et al.  Microglia are required for protection against lethal coronavirus encephalitis in mice , 2018, The Journal of clinical investigation.

[23]  A. Crawshaw,et al.  Human T-cell lymphotropic virus (HTLV)-associated encephalopathy: an under-recognised cause of acute encephalitis? Case series and literature review , 2018, Journal of Neurology.

[24]  G. Khan,et al.  Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells , 2018, PloS one.

[25]  S. Harakeh,et al.  HTLV-1 Associated Neurological Disorders. , 2017, Current topics in medicinal chemistry.

[26]  Christopher M. Bland,et al.  Management of Viral Central Nervous System Infections: A Primer for Clinicians , 2017, Journal of central nervous system disease.

[27]  Y. Yamano,et al.  HTLV-1 induces a Th1-like state in CD4+ CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP , 2017, Journal of Neuroimmunology.

[28]  M. Azarpazhooh,et al.  Altered expression of CXCR3 and CCR6 and their ligands in HTLV‐1 carriers and HAM/TSP patients , 2017, Journal of medical virology.

[29]  H. Feldmann,et al.  Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters , 2016, PLoS neglected tropical diseases.

[30]  Roger N Gunn,et al.  Evidence of Brain Inflammation in Patients with Human T-Lymphotropic Virus Type 1–Associated Myelopathy (HAM): A Pilot, Multimodal Imaging Study Using 11C-PBR28 PET, MR T1-Weighted, and Diffusion-Weighted Imaging , 2016, The Journal of Nuclear Medicine.

[31]  Toshihide Yamashita,et al.  Microglia in central nervous system repair after injury. , 2016, Journal of biochemistry.

[32]  Peixiang Ni,et al.  Detection of virus in CSF from the cases with meningoencephalitis by next-generation sequencing , 2016, Journal of NeuroVirology.

[33]  I. Marriott,et al.  RIG‐I is required for VSV‐induced cytokine production by murine glia and acts in combination with DAI to initiate responses to HSV‐1 , 2015, Glia.

[34]  R. Leak,et al.  Demyelination as a rational therapeutic target for ischemic or traumatic brain injury , 2015, Experimental Neurology.

[35]  L. Enquist,et al.  Axonal spread of neuroinvasive viral infections. , 2015, Trends in microbiology.

[36]  I. Lizasoain,et al.  Rational modulation of the innate immune system for neuroprotection in ischemic stroke , 2015, Front. Neurosci..

[37]  F. Cosset,et al.  Heparan Sulfate-Dependent Enhancement of Henipavirus Infection , 2015, mBio.

[38]  B. Horvat,et al.  Henipavirus pathogenesis and antiviral approaches , 2015, Expert review of anti-infective therapy.

[39]  M. Yoneyama,et al.  Viral RNA detection by RIG-I-like receptors. , 2015, Current opinion in immunology.

[40]  Yuetsu Tanaka,et al.  Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis , 2015, Journal of neuropathology and experimental neurology.

[41]  G. Barton,et al.  Emerging principles governing signal transduction by pattern-recognition receptors. , 2015, Cold Spring Harbor perspectives in biology.

[42]  Suhailah Abdullah,et al.  Henipavirus encephalitis. , 2014, Handbook of clinical neurology.

[43]  D. Sulzer,et al.  MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration , 2014, Nature Communications.

[44]  J. Brady,et al.  Gem-Induced Cytoskeleton Remodeling Increases Cellular Migration of HTLV-1-Infected Cells, Formation of Infected-to-Target T-Cell Conjugates and Viral Transmission , 2014, PLoS pathogens.

[45]  A. Utsunomiya,et al.  Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. , 2013, Brain : a journal of neurology.

[46]  V. Perry,et al.  Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration , 2013, Seminars in Immunopathology.

[47]  V. Borisevich,et al.  Pathogenesis of Hendra and Nipah virus infection in humans. , 2013, Journal of infection in developing countries.

[48]  H. Feldmann,et al.  Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route , 2012, Scientific Reports.

[49]  C. Richardson,et al.  Nectin 4 is the epithelial cell receptor for measles virus. , 2012, Trends in microbiology.

[50]  P. Kubes,et al.  Immune surveillance in the central nervous system , 2012, Nature Neuroscience.

[51]  M. Prevost,et al.  Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells. , 2012, Blood.

[52]  I. Marriott,et al.  Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation , 2012, Front. Microbio..

[53]  N. Beeching,et al.  Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. , 2012, The Journal of infection.

[54]  V. Guillaume,et al.  Lethal Nipah Virus Infection Induces Rapid Overexpression of CXCL10 , 2012, PloS one.

[55]  H. Weingartl,et al.  Nipah Virus Infects Specific Subsets of Porcine Peripheral Blood Mononuclear Cells , 2012, PloS one.

[56]  M. David,et al.  Immunomodulatory functions of type I interferons , 2012, Nature Reviews Immunology.

[57]  Joshua A. Smith,et al.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.

[58]  P. Chan,et al.  Neuroprotection by Interleukin-6 Is Mediated by Signal Transducer and Activator of Transcription 3 and Antioxidative Signaling in Ischemic Stroke , 2011, Stroke.

[59]  K. Cichutek,et al.  Adherens junction protein nectin-4 (PVRL4) is the epithelial receptor for measles virus , 2011, Nature.

[60]  R. Giffard,et al.  Astrocytes: targets for neuroprotection in stroke. , 2011, Central nervous system agents in medicinal chemistry.

[61]  F. Cosset,et al.  Nipah Virus Uses Leukocytes for Efficient Dissemination within a Host , 2011, Journal of Virology.

[62]  A. Tolkovsky,et al.  Inhibition of Microglial Phagocytosis Is Sufficient To Prevent Inflammatory Neuronal Death , 2011, The Journal of Immunology.

[63]  M. Nagai,et al.  Human T-cell lymphotropic virus type I and neurological diseases , 2003, Journal of NeuroVirology.

[64]  H. Neumann,et al.  Protective effects of microglia in multiple sclerosis , 2010, Experimental Neurology.

[65]  V. Grdzelishvili,et al.  Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses. , 2010, Virology.

[66]  Richard M. Page,et al.  Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease , 2010, Nature Neuroscience.

[67]  C. Long-Smith,et al.  The influence of microglia on the pathogenesis of Parkinson's disease , 2009, Progress in Neurobiology.

[68]  A. Pol.  Viral Infection Leading to Brain Dysfunction: More Prevalent Than Appreciated? , 2009, Neuron.

[69]  A. Becker,et al.  CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. , 2009, Brain : a journal of neurology.

[70]  Aidan MacNamara,et al.  The Avidity and Lytic Efficiency of the CTL Response to HTLV-11 , 2009, The Journal of Immunology.

[71]  G. Zoppo.  Inflammation and the neurovascular unit in the setting of focal cerebral ischemia , 2009, Neuroscience.

[72]  P. Couraud,et al.  Alteration of Blood–Brain Barrier Integrity by Retroviral Infection , 2008, PLoS pathogens.

[73]  R. Garg.  Subacute sclerosing panencephalitis , 2008, Journal of Neurology.

[74]  Charles R. M. Bangham.  HTLV-1 infection: role of CTL efficiency , 2008, Blood.

[75]  M. Ekstrand,et al.  The alpha-herpesviruses: molecular pathfinders in nervous system circuits. , 2008, Trends in molecular medicine.

[76]  S. Miller,et al.  Glial toll-like receptor signaling in central nervous system infection and autoimmunity , 2008, Brain, Behavior, and Immunity.

[77]  R. Diefenbach,et al.  Transport and egress of herpes simplex virus in neurons , 2008, Reviews in medical virology.

[78]  J. Oliveira-Filho,et al.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP. , 2007, AIDS research and human retroviruses.

[79]  Tom Solomon,et al.  Viral encephalitis: a clinician’s guide , 2007, Practical Neurology.

[80]  J. Sejvar.  The long-term outcomes of human West Nile virus infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  J. Hiscott.  Triggering the Innate Antiviral Response through IRF-3 Activation* , 2007, Journal of Biological Chemistry.

[82]  Benhur Lee.  Envelope–Receptor Interactions in Nipah Virus Pathobiology , 2007, Annals of the New York Academy of Sciences.

[83]  S. Jacobson,et al.  Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I , 2007, Neurology.

[84]  T. Kielian.  Toll‐like receptors in central nervous system glial inflammation and homeostasis , 2006, Journal of neuroscience research.

[85]  P. Monk,et al.  Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis , 2005, Glia.

[86]  Y. Berhane,et al.  Invasion of the Central Nervous System in a Porcine Host by Nipah Virus , 2005, Journal of Virology.

[87]  T. Hökfelt,et al.  A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[88]  R. Howard,et al.  Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[89]  C. Lim,et al.  Neuropsychiatric sequelae of Nipah virus encephalitis. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[90]  F. Mostashari,et al.  Long-Term Prognosis for Clinical West Nile Virus Infection , 2004, Emerging infectious diseases.

[91]  P. Spano,et al.  Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices , 2004, Molecular and Cellular Neuroscience.

[92]  S. Sato,et al.  Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections , 2003, Neurology.

[93]  P. Loth,et al.  A golden hamster model for human acute Nipah virus infection. , 2003, The American journal of pathology.

[94]  B. Anlar,et al.  Acute Disseminated Encephalomyelitis in Children: Outcome and Prognosis , 2003, Neuropediatrics.

[95]  K. Wong,et al.  Nipah encephalitis outbreak in Malaysia. , 2003, Annals of the Academy of Medicine, Singapore.

[96]  J. Guarner,et al.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. , 2002, The American journal of pathology.

[97]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[98]  M. Kitajima,et al.  Central nervous system lesions in adult T-cell leukaemia: MRI and pathology , 2002, Neuroradiology.

[99]  K. Tan,et al.  Relapsed and late‐onset Nipah encephalitis , 2002, Annals of neurology.

[100]  L. Enquist,et al.  Directional spread of an α-herpesvirus in the nervous system , 2002 .

[101]  E. Benveniste,et al.  Immune function of astrocytes , 2001, Glia.

[102]  M. Wong,et al.  Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response , 2001, Journal of neurology, neurosurgery, and psychiatry.

[103]  U. Parashar,et al.  Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. , 2001, Emerging infectious diseases.

[104]  M. Dailey,et al.  Dynamics of microglial activation: A confocal time‐lapse analysis in hippocampal slices , 2001, Glia.

[105]  S. Jacobson,et al.  Viruses and multiple sclerosis. , 2012, Viral immunology.

[106]  K. Chua,et al.  Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. , 2000, The New England journal of medicine.

[107]  W. Bellini,et al.  Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[108]  Y. Itoyama,et al.  [A case of encephalomyeloneuritis and HTLV-I infection]. , 1999, No to shinkei = Brain and nerve.

[109]  E. Castaños-Vélez,et al.  Measles virus antigen in macrophage/microglial cells and astrocytes of subacute sclerosing panencephalitis , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[110]  J. Durkin,et al.  Stimulation of glutamate uptake and Na, K‐ATPase activity in rat astrocytes exposed to ischemia‐like insults , 1997, Glia.

[111]  L. Lampson.  Interpreting MHC class I expression and class I/class II reciprocity in the CNS: Reconciling divergent findings , 1995, Microscopy research and technique.

[112]  P. A. Schad,et al.  Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[113]  R. Jacobson,et al.  Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. , 1994, Archives of internal medicine.

[114]  N. Tachi,et al.  Acute disseminated encephalomyelitis following HTLV-I associated myelopathy , 1992, Journal of the Neurological Sciences.

[115]  S. Izumo,et al.  Neuropathology of HTLV‐I‐Associated Myelopathy—A Report of Two Autopsy Cases— , 1992, Acta paediatrica Japonica : Overseas edition.

[116]  L. Samkoff,et al.  Recurrent encephalopathy and seizures in a US native with HTLV‐I‐associated myelopathy/tropical spastic paraparesis , 1992, Neurology.

[117]  F. Fonnum,et al.  Persistent changes in behaviour and brain serotonin during ageing in rats subjected to infant nasal virus infection , 1992, Neurobiology of Aging.

[118]  A. Fauci,et al.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease , 1990, Nature.

[119]  S. Araga,et al.  Subacute meningoencephalitis associated with human T‐lymphotrophic virus Type I (HTLV‐I) Report of a case , 1989, Acta neurologica Scandinavica.

[120]  J. Hess,et al.  Immune Responses in the Central Nervous System , 1987, Toxicologic pathology.

[121]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.